Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction.
about
Fibroblasts, an inconspicuous but essential player in colon cancer development and progressionOsteopontin-A Master Regulator of Epithelial-Mesenchymal TransitionCytokine-Induced Modulation of Colorectal CancerPotential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancerCancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor GrowthImmune cell interplay in colorectal cancer prognosisRole of cancer-associated fibroblasts in invasion and metastasis of gastric cancerHematopoietic stem cell-derived adipocytes and fibroblasts in the tumor microenvironmentCytokines, IBD, and colitis-associated cancerIL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathwayMicroenvironmental regulation of therapeutic response in cancerInterleukin-6 mediated upregulation of CYP1B1 and CYP2E1 in colorectal cancer involves DNA methylation, miR27b and STAT3.Concise review: The obesity cancer paradigm: exploration of the interactions and crosstalk with adipose stem cells.Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment.IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.Antagonizing pathways leading to differential dynamics in colon carcinogenesis in Shugoshin1 (Sgo1)-haploinsufficient chromosome instability modelInterleukin-1 Receptor Type 2 Acts with c-Fos to Enhance the Expression of Interleukin-6 and Vascular Endothelial Growth Factor A in Colon Cancer Cells and Induce Angiogenesis.Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated PeritonitisThe Mutant KRAS Gene Up-regulates BCL-XL Protein via STAT3 to Confer Apoptosis Resistance That Is Reversed by BIM Protein Induction and BCL-XL AntagonismImmunity, inflammation, and cancer: an eternal fight between good and evil.Humanized anti-hepatocyte growth factor (HGF) antibody suppresses innate irinotecan (CPT-11) resistance induced by fibroblast-derived HGF.Dimethylarginine dimethylaminohydrolase 2 promotes tumor angiogenesis in lung adenocarcinoma.IL-6 Inhibition Reduces STAT3 Activation and Enhances the Antitumor Effect of Carboplatin.Significance of Interleukin-6 in Papillary Thyroid Carcinoma.Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway.Prognostic role of serum concentrations of high-sensitivity C-reactive protein in patients with metastatic colorectal cancer: results from the ITACa trialPrognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy.Heterogeneity of proangiogenic features in mesenchymal stem cells derived from bone marrow, adipose tissue, umbilical cord, and placenta.Dragon (RGMb) induces oxaliplatin resistance in colon cancer cells.Genetic alterations and epigenetic alterations of cancer-associated fibroblasts.Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways.Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.Update on implications and mechanisms of angiogenesis in liver fibrosis.Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts.Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer.Perspective of Targeting Cancer-Associated Fibroblasts in Melanoma.Emerging cytokine networks in colorectal cancer.Mechanism of action of selective inhibitors of IL-6 induced STAT3 pathway in head and neck cancer cell lines.The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.
P2860
Q26747341-3EC339C6-E6C9-4780-9440-74BD85858913Q26749570-1FA9B53C-C219-48DA-B5DB-A99A31290CA1Q26752374-30A68625-2048-4816-9A49-BBE21E67D2B8Q26769917-9F569E14-310B-4694-A95C-7EE03D58A83CQ26774159-456C91AC-6631-4B61-9DAB-4BBD78334FCCQ26781453-D1E93D97-9F1F-4051-8795-9667990D910BQ26781520-47253F08-74C1-4651-B0B0-9A8D4FF71CB7Q28080529-D874668D-F935-4002-A1B7-66511CC2F7C2Q28080901-1C478D7D-0523-49E9-A333-0D5AE31F6FE4Q33591332-C22989E5-FA0D-472E-AAA7-AAFEEFDF78FBQ33654609-9D6B8B0F-F2D5-43C5-870F-83965CDF5EE5Q34687041-B48FE01C-76B5-401D-86D3-806921E9EA28Q35111874-8A124608-12FA-49C9-94F7-2D012E1D862EQ35578981-153BEFFD-10F4-453C-B870-A30233321447Q35717574-3EC77DE1-84F1-4DF2-A3DE-B45ED93C65CEQ36059007-1BF0C90A-774A-48CD-8F12-5ADF16485E4BQ36065268-3608065C-A6D0-419D-A5C8-A4F77FFA9E2FQ36092550-AE31D45A-CA8D-4205-8D14-7EF055D3ED1DQ36092931-A7652CCF-A923-4162-92F9-571C751FA704Q36106053-0A48FF52-56E2-4E2B-8BCA-ED3DFF4BBF22Q36414376-6F8C74F1-0AAD-497C-99E3-2D6AB141C4C5Q36651307-6E94FD27-E70B-4DD2-82B6-04B84DF13B36Q36661347-955CE7F3-7ECE-45F1-9D46-A9E46BD755C8Q36731164-437577EE-45BB-4EBE-A685-E1D5B5D31590Q36878675-D9EBF77A-36E3-49F6-A2F5-2FFEE29F77A4Q36962915-91B47E92-7FBA-4FF7-877C-468F41FCB4C9Q37059793-91604BDF-7009-4078-892D-42C8817D85A3Q37405861-DA2A288A-C145-43CF-B88F-91A88F9EFA28Q37565369-BB8A2DB5-D34E-412A-8C46-02FF14947BB2Q37594099-6BA93F23-E074-4FC2-A12A-6F0AB7FA3F03Q37645095-A7FD4511-FC5E-4C1D-8BB7-064364D00C78Q37671165-C12A11C6-4C20-425A-91B7-D85E67E45D49Q37703500-848742AE-47C4-4E37-B794-3888CF3E7DB3Q38246718-5D0DBA72-49F6-41F6-9590-57441A7CA3B6Q38354860-AC3DE2F9-C6BE-4875-82B3-17B0EFFAA75DQ38411234-56D6220E-66AC-48D2-B1C2-C715351702EAQ38549236-97A67801-DC9D-4757-B499-3AFC379B6836Q38584430-853773C0-9F72-4729-854E-1B53E826884DQ38690169-FFAC8512-A3A4-4F10-A8A3-994D3C22CE3DQ38834441-504E5418-66D1-4A6A-BB25-1A4C375E27EC
P2860
Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interleukin-6 released by colo ...... ted tumour-stroma interaction.
@en
Interleukin-6 released by colo ...... ted tumour-stroma interaction.
@nl
type
label
Interleukin-6 released by colo ...... ted tumour-stroma interaction.
@en
Interleukin-6 released by colo ...... ted tumour-stroma interaction.
@nl
prefLabel
Interleukin-6 released by colo ...... ted tumour-stroma interaction.
@en
Interleukin-6 released by colo ...... ted tumour-stroma interaction.
@nl
P2093
P2860
P356
P1476
Interleukin-6 released by colo ...... ted tumour-stroma interaction.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.2013.748
P407
P577
2013-12-17T00:00:00Z
P5875
P6179
1019388641